BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 10977134)

  • 21. Effects of coronary artery disease on expression and microvascular response to VEGF.
    Métais C; Li J; Li J; Simons M; Sellke FW
    Am J Physiol; 1998 Oct; 275(4):H1411-8. PubMed ID: 9746492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells.
    Takahashi T; Ueno H; Shibuya M
    Oncogene; 1999 Apr; 18(13):2221-30. PubMed ID: 10327068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
    Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of vascular endothelial growth factor receptors in smooth muscle cells.
    Ishida A; Murray J; Saito Y; Kanthou C; Benzakour O; Shibuya M; Wijelath ES
    J Cell Physiol; 2001 Sep; 188(3):359-68. PubMed ID: 11473363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer.
    Itakura J; Ishiwata T; Shen B; Kornmann M; Korc M
    Int J Cancer; 2000 Jan; 85(1):27-34. PubMed ID: 10585578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.
    Takahashi T; Yamaguchi S; Chida K; Shibuya M
    EMBO J; 2001 Jun; 20(11):2768-78. PubMed ID: 11387210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
    Boocock CA; Charnock-Jones DS; Sharkey AM; McLaren J; Barker PJ; Wright KA; Twentyman PR; Smith SK
    J Natl Cancer Inst; 1995 Apr; 87(7):506-16. PubMed ID: 7707437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells.
    Suzuma K; Takagi H; Otani A; Honda Y
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):1028-35. PubMed ID: 9579483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts.
    Takahashi T; Shibuya M
    Oncogene; 1997 May; 14(17):2079-89. PubMed ID: 9160888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1).
    Yamane A; Seetharam L; Yamaguchi S; Gotoh N; Takahashi T; Neufeld G; Shibuya M
    Oncogene; 1994 Sep; 9(9):2683-90. PubMed ID: 8058332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGF.
    Wang D; Donner DB; Warren RS
    J Biol Chem; 2000 May; 275(21):15905-11. PubMed ID: 10748050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.
    Rousseau S; Houle F; Landry J; Huot J
    Oncogene; 1997 Oct; 15(18):2169-77. PubMed ID: 9393975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells.
    Suzuma K; Naruse K; Suzuma I; Takahara N; Ueki K; Aiello LP; King GL
    J Biol Chem; 2000 Dec; 275(52):40725-31. PubMed ID: 11018037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
    Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N
    Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective killing of RPE with a vascular endothelial growth factor chimeric toxin.
    Hoffmann S; Masood R; Zhang Y; He S; Ryan SJ; Gill P; Hinton DR
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2389-93. PubMed ID: 10892888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis.
    Baek JH; Jang JE; Kang CM; Chung HY; Kim ND; Kim KW
    Oncogene; 2000 Sep; 19(40):4621-31. PubMed ID: 11030151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flk-1 as a target for tumor growth inhibition.
    Strawn LM; McMahon G; App H; Schreck R; Kuchler WR; Longhi MP; Hui TH; Tang C; Levitzki A; Gazit A; Chen I; Keri G; Orfi L; Risau W; Flamme I; Ullrich A; Hirth KP; Shawver LK
    Cancer Res; 1996 Aug; 56(15):3540-5. PubMed ID: 8758924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.